Biolife solutions to participate in upcoming investor conferences in may and june 2025

Bothell, wash. , may 14, 2025 /prnewswire/ -- biolife solutions, inc. (nasdaq: blfs), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("cgt") market, today announced the company will be participating in the following investor conferences: 22nd annual craig-hallum institutional investor conference may 28, 2025 minneapolis, mn at the renaissance hotel benchmark 2025 healthcare house call virtual conference may 29, 2025 virtual jefferies global life sciences conference june 3 – 5, 2025 new york, ny at the marriott marquis wolfe research small & mid-cap conference june 5, 2025 new york, ny at wolfe headquarters northland growth conference 2025 june 25, 2025 virtual about biolife solutions biolife solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (cgt) and broader biopharma markets.
BLFS Ratings Summary
BLFS Quant Ranking